Genetic Epidemiology Unit of the Department of Epidemiology, Erasmus MC University Medical Center Rotterdam, The Netherlands.
Neurobiol Aging. 2011 Sep;32(9):1607-14. doi: 10.1016/j.neurobiolaging.2009.10.011. Epub 2009 Nov 18.
Cathepsin D (CTSD) is a gene involved in amyloid precursor protein processing and is considered a candidate for Alzheimer's disease (AD). The aim of the current study was to examine if variation in CTSD increases the risk of AD. We performed a candidate-gene analysis in a population-based cohort study (N=7983), and estimated the effect of CTSD on the risk of AD. Additionally, a large meta-analysis was performed incorporating our data and previously published data. The T-allele of CTSD rs17571 was associated with an increased risk of AD (p-value 0.007) in the Rotterdam Study. This association was predominantly found in APOE ε4 noncarriers. A meta-analysis of previously published data showed a significantly increased risk of AD in carriers of the T-allele of rs17571 (OR 1.22, 95% CI 1.03-1.44), irrespective of APOE ε4 carrier status. This study adds to the evidence that CTSD increases the risk of AD, although the effect size is moderate.
组织蛋白酶 D (CTSD) 是参与淀粉样前体蛋白加工的基因,被认为是阿尔茨海默病 (AD) 的候选基因。本研究旨在探讨 CTSD 变异是否会增加 AD 的风险。我们在基于人群的队列研究 (N=7983) 中进行了候选基因分析,并估计了 CTSD 对 AD 风险的影响。此外,还进行了一项大型荟萃分析,纳入了我们的数据和先前发表的数据。在鹿特丹研究中,CTSD rs17571 的 T 等位基因与 AD 的风险增加相关(p 值为 0.007)。这种关联主要发生在 APOE ε4 非携带者中。对先前发表的数据的荟萃分析显示,rs17571 的 T 等位基因携带者患 AD 的风险显著增加(OR 1.22,95%CI 1.03-1.44),无论 APOE ε4 携带状态如何。这项研究增加了 CTSD 会增加 AD 风险的证据,尽管效应大小适中。